Bangavax, Bangladesh's homegrown COVID vaccine, receives US patent

Globe Biotech claims the US patent is the first in the history of the pharmaceutical industry in Bangladesh. Globe Biotech held a press conference at the head office of Globe Pharmaceuticals in the Tejgaon Industrial Area on Sunday. Afterwards, Globe Biotech said in a statement that as people around the world were struggling during the coronavirus pandemic, research work began on “COVID-19” detection kits, vaccines and drugs for the needs of the nation under the overall supervision of the company's scientists Kakon Nag and Naznin Sultana. The “COVID-19 mRNA” vaccine developed in that study was approved for clinical trial by the Bangladesh Medical Research Council (BMRC) and the Directorate General of Drug Administration (DGDA). First, the complete coding sequence of...